EDF Ventures logo

EDF Ventures

North America, Michigan, United States, Ann Arbor

Description

EDF Ventures is a leading venture capital firm investing in early-stage healthcare companies.

Investor Profile

EDF Ventures has made 48 investments, with 0 in the past 12 months and 8% as lead.

Stage Focus

  • Series B (27%)
  • Series A (21%)
  • Series Unknown (21%)
  • Series C (17%)
  • Series D (8%)
  • Debt Financing (2%)
  • Seed (2%)
  • Secondary Market (2%)

Country Focus

  • United States (90%)
  • France (8%)
  • United Kingdom (2%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical Device
  • Medical
  • Manufacturing
  • Software
  • Telecommunications
  • Health Diagnostics
  • Analytics
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does EDF Ventures frequently co-invest with?

New Leaf Venture Partners
North America, New York, United States, New York
Co-Investments: 3
Spray Venture Partners
North America, Massachusetts, United States, Newton
Co-Investments: 4
Johnson & Johnson Development Corporation
North America, New Jersey, United States, New Brunswick
Co-Investments: 3
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 3
Dawntreader Ventures
North America, New York, United States, New York
Co-Investments: 3
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 3
Mission Ventures
North America, California, United States, San Diego
Co-Investments: 4
Affinity Capital Management
North America, Minnesota, United States, Minneapolis
Co-Investments: 3
VantagePoint Capital Partners
North America, California, United States, San Bruno
Co-Investments: 4
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 4

Which angels does EDF Ventures often collaborate with?

GT
North America, Indiana, United States, Carmel
Shared Deals: 1

What are some of recent deals done by EDF Ventures?

BeZero Carbon

London, England, United Kingdom

The carbon ratings agency.

Information ServicesInformation Technology
Series BNov 14, 2022
Amount Raised: $50,000,000
DataBank

Dallas, Texas, United States

DataBank is an information management and security company offering customized technology solutions to businesses.

ConsultingInformation TechnologyRisk Management
Secondary MarketAug 30, 2022
Amount Raised: $1,500,000,000
IntelePeer

San Mateo, California, United States

IntelePeer is a communications automation platform utilizing AI to enhance interactions.

MessagingPaaSSMSTelecommunicationsVoIP
Series DJun 10, 2013
Amount Raised: $15,000,000
Direct Flow Medical

Santa Rosa, California, United States

Direct Flow Medical designs and develops medical implants used in the treatment of aortic and heart valve diseases.

Health CareMedicalMedical Device
Series UnknownApr 1, 2012
Amount Raised: $284,000
TransCorp Spine

Grand Rapids, Michigan, United States

TransCorp is a medical device company developing and commercializing surgical instruments and implants.

BiotechnologyIntrusion DetectionLife ScienceMedical DevicemHealth
Series AMay 12, 2011
Amount Raised: $755,000
Sonoma Orthopedics

Santa Rosa, California, United States

Sonoma Orthopedic Products designs, develops and delivers proprietary orthopedic implants for physicians to treat problematic fractures.

BiotechnologyHealth CareHospitalMedical Device
Series DFeb 14, 2011
Amount Raised: $22,000,000
Abionyx Pharma

Balma, Midi-Pyrenees, France

ABIONYX Pharma is a biotech company discovering and developing innovative therapies for patients without existing or effective treatment.

BiotechnologyHealth Care
Series CJul 25, 2010
Amount Raised: $64,503,894
Direct Flow Medical

Santa Rosa, California, United States

Direct Flow Medical designs and develops medical implants used in the treatment of aortic and heart valve diseases.

Health CareMedicalMedical Device
Series COct 5, 2009
Amount Raised: $40,000,000
ValenTx

Maple Grove, Minnesota, United States

ValenTx is a development-stage medical device company that focuses on minimally-invasive methods for the treatment of morbid obesity.

Health CareMedical Device
Series BSep 8, 2009
Amount Raised: $22,000,000
Lycera

Ann Arbor, Michigan, United States

Lycera engages in the development of small-molecule immunomodulators for the treatment of patients with autoimmune diseases.

BiopharmaBiotechnologyPharmaceutical
Series AMay 5, 2009
Amount Raised: $36,000,000